再赚180万，2026年的投资计划~（周报328期）

Core Insights - The company achieved a total profit of 1.843 million in 2025, with a return rate of 33.89% [1][14] - The company primarily operates three investment accounts: on-exchange ETF account, off-exchange fund account, and advisory portfolio account [1] On-Exchange ETF Account - The on-exchange ETF account reported a profit of 438,046.77, with a return rate of 39.01% for 2025 [4] - The account's core holdings include Hong Kong innovation drug ETF, Hong Kong technology ETF, and Hong Kong consumer ETF, focusing on the Hong Kong market [4][5] - The account has shown stability, with 9 out of 12 months being profitable, indicating a monthly win rate of 75% [4] Off-Exchange Fund Account - The off-exchange fund account has assets of 5.4 million, with a profit of 1.325 million and a return rate of 33.89% [3][8] - The account's main holdings are in resource and technology funds, with significant contributions from resource funds [9] - The account has also shown stability, with 8 out of 12 months being profitable, resulting in a monthly win rate of over 66% [9] Advisory Portfolio Account - The advisory portfolio account has assets exceeding 1.2 million, with a cumulative profit of around 80,000 [13] - The portfolio focuses on long-term investments, with holdings in various funds, including medical and consumer sectors [13] - The account's strategy includes maintaining a maximum position of 15% in any single sector to manage risk [12][13] Market Outlook for 2026 - The company plans to adopt a more defensive strategy in 2026 due to high valuations in the A-share market, while the Hong Kong market remains relatively reasonable [17][18] - The company aims to reduce its overall position to around 60% if the market continues to rise, focusing on undervalued sectors with potential [21] - Key sectors for 2026 include Hong Kong technology, defense industry, and innovative pharmaceuticals, which together represent 50% of the overall portfolio [26][27]